FDA Staff Offer Tips On Medical Device Reporting At AAMI Event
This article was originally published in The Gray Sheet
Consider this scenario: A company receives a complaint which it suspects represents a reportable device malfunction. Two weeks later, the firm obtains the implicated device. A subsequent four-week investigation confirms the malfunction, which the company then reports to FDA. Has the firm complied with the agency's 30-day reporting deadline
You may also be interested in...
Previous businesses FDA warned about COVID-19 claims for chlorine dioxide, a bleach solution, were marketing dietary supplements unlawfully. But Pro Breath MD's oral rinses available under the Dentist Select and OraCare brands are allowed and FDA isn’t asking the firm to discontinue distribution.
The Stark Law ban on self-referrals wouldn’t apply to some physician owners of advanced imaging facilities under a CMS final rule.
Pfizer’s abrocitinib and Biogen/Eisai’s aducanumab are among a host of new investigational products that are under review by the European Medicines Agency.